Pompe disease, a rare and debilitating genetic disorder, has garnered increased attention in the medical community and pharmaceutical industry in recent years. This heightened interest is largely due to significant advancements in the treatment landscape for this condition. Pompe disease, also known as glycogen storage disease type II, is an autosomal recessive disorder caused by a deficiency...